Blood-Based Biomarkers for Cancer Immunotherapy: Tumor Mutational Burden in Blood (bTMB) is Associated with Improved Atezolizumab (atezo) Efficacy in 2L+ NSCLC (POPLAR and OAK)
| Autor: | Christine Malboeuf, David S. Shames, Wei Zou, Todd Riehl, David Fabrizio, Alan Sandler, Craig Cummings, Achim Rittmeyer, Lukas C. Amler, G. Otto, Priti S. Hegde, Louis Fehrenbacher, Tony Mok, Erica B. Schleifman, Daniel S. Lieber, Marcin Kowanetz, David R. Gandara, Marcus Ballinger, Sarah M. Paul |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Blood based biomarkers business.industry medicine.medical_treatment Hematology 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Cancer immunotherapy Atezolizumab 030220 oncology & carcinogenesis Internal medicine Immunology medicine business |
| Zdroj: | ResearcherID Publons |
| ISSN: | 1438-8790 0934-8387 |
| DOI: | 10.1055/s-0037-1619250 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|